Thus, many potential biomarkers for the diagnosis and evaluation of BC progression have been identified in peripheral blood by assessing the expressions of human mammoglobin A (MAM) mRNA [187], ERBB2/HER2 mRNA [188,189], EPCAM, KRT19, MKI67, TERT, VIM, NPTN, MCAM, SNAI2, and FOXA2 mRNAs [190]. The gene discussed is ERBB2; the disease is breast cancer.